A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer
Gerald Schmid‐Bindert(Heidelberg University), Walburga Engel-Riedel(Kliniken der Stadt Köln), Martin Reck(German Center for Lung Research), Wolfgang Schuette(Martha-Maria Hospital), J. Stöhlmacher(Evonik (Germany)), Jürgen R. Fischer(Löwenstein Medical (Germany)), Julien Mazières(Hôpital Larrey), C. Chouaïd(Hôpital Intercommunal de Créteil), M. Wolf(Klinikum Kassel), Núria Viñolas(Hospital Clínic de Barcelona), Victoria Soldatenkova(Eli Lilly (Germany)), Veronique Ripoche(Clinique Hartmann), Tuan S. Nguyen(Eli Lilly (United States)), Carla Visseren‐Grul(Eli Lilly (Netherlands))
Cited by 13
Abstract
Related Papers
No related papers found
Powered by citation graph analysis